City View Green Holdings Inc. (CVGR.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -996.45 Thousand CAD | 52.84% |
| 2022 | -2.11 Million CAD | 21.51% |
| 2021 | -2.69 Million CAD | 49.39% |
| 2020 | -5.31 Million CAD | -1.24% |
| 2019 | -5.25 Million CAD | -448.9% |
| 2018 | -957.24 Thousand CAD | -208.32% |
| 2017 | -310.47 Thousand CAD | -157.87% |
| 2016 | -120.39 Thousand CAD | 0.03% |
| 2015 | -120.43 Thousand CAD | -12.6% |
| 2014 | -106.95 Thousand CAD | 72.81% |
| 2013 | -393.36 Thousand CAD | 68.32% |
| 2012 | -1.24 Million CAD | 33.22% |
| 2011 | -1.85 Million CAD | 5.02% |
| 2010 | -1.95 Million CAD | -83.99% |
| 2009 | -1.06 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -155.64 Thousand CAD | 33.58% |
| 2024 Q2 | -219.63 Thousand CAD | -41.11% |
| 2023 Q2 | -242.82 Thousand CAD | -2.37% |
| 2023 Q4 | -234.32 Thousand CAD | 13.96% |
| 2023 FY | -996.45 Thousand CAD | 52.84% |
| 2023 Q1 | -237.21 Thousand CAD | 54.62% |
| 2023 Q3 | -272.33 Thousand CAD | -12.15% |
| 2022 FY | -2.11 Million CAD | 21.51% |
| 2022 Q4 | -522.76 Thousand CAD | 4.12% |
| 2022 Q3 | -545.21 Thousand CAD | 3.27% |
| 2022 Q2 | -563.65 Thousand CAD | -17.13% |
| 2022 Q1 | -481.24 Thousand CAD | 81.85% |
| 2021 Q2 | -505.22 Thousand CAD | -35.0% |
| 2021 Q4 | -2.65 Million CAD | -431.95% |
| 2021 Q1 | -374.23 Thousand CAD | 84.22% |
| 2021 FY | -2.69 Million CAD | 49.39% |
| 2021 Q3 | -498.32 Thousand CAD | 1.37% |
| 2020 Q1 | -404.82 Thousand CAD | 65.83% |
| 2020 FY | -5.31 Million CAD | -1.24% |
| 2020 Q2 | -689.25 Thousand CAD | -70.26% |
| 2020 Q3 | -1.85 Million CAD | -169.86% |
| 2020 Q4 | -2.37 Million CAD | -27.5% |
| 2019 Q2 | -1.47 Million CAD | -80.36% |
| 2019 Q3 | -850.31 Thousand CAD | 42.42% |
| 2019 Q4 | -1.18 Million CAD | -39.34% |
| 2019 FY | -5.25 Million CAD | -448.9% |
| 2019 Q1 | -818.78 Thousand CAD | -580.11% |
| 2018 Q1 | -641.69 Thousand CAD | -444.14% |
| 2018 Q2 | -115.17 Thousand CAD | 82.05% |
| 2018 Q4 | -120.39 Thousand CAD | -50.52% |
| 2018 FY | -957.24 Thousand CAD | -208.32% |
| 2018 Q3 | -79.98 Thousand CAD | 30.55% |
| 2017 Q3 | -72.19 Thousand CAD | -39.37% |
| 2017 Q2 | -51.8 Thousand CAD | 24.43% |
| 2017 Q1 | -68.54 Thousand CAD | 2.25% |
| 2017 FY | -310.47 Thousand CAD | -157.87% |
| 2017 Q4 | -117.92 Thousand CAD | -63.34% |
| 2016 FY | -120.39 Thousand CAD | 0.03% |
| 2016 Q3 | -15.65 Thousand CAD | 10.52% |
| 2016 Q1 | -17.12 Thousand CAD | 7.77% |
| 2016 Q4 | -70.12 Thousand CAD | -347.88% |
| 2016 Q2 | -17.49 Thousand CAD | -2.2% |
| 2015 Q3 | -31.27 Thousand CAD | -51.83% |
| 2015 Q4 | -18.56 Thousand CAD | 40.64% |
| 2015 FY | -120.43 Thousand CAD | -12.6% |
| 2015 Q2 | -20.59 Thousand CAD | 58.81% |
| 2015 Q1 | -50 Thousand CAD | -261.62% |
| 2014 Q4 | 30.94 Thousand CAD | 167.88% |
| 2014 Q3 | -45.57 Thousand CAD | 6.94% |
| 2014 FY | -106.95 Thousand CAD | 72.81% |
| 2014 Q1 | -43.23 Thousand CAD | -9.27% |
| 2014 Q2 | -48.97 Thousand CAD | -13.28% |
| 2013 Q3 | -77.06 Thousand CAD | 36.28% |
| 2013 Q4 | -39.56 Thousand CAD | 48.66% |
| 2013 FY | -393.36 Thousand CAD | 68.32% |
| 2013 Q1 | -157.14 Thousand CAD | 62.16% |
| 2013 Q2 | -120.94 Thousand CAD | 23.03% |
| 2012 Q4 | -415.27 Thousand CAD | -67.92% |
| 2012 Q2 | -304.32 Thousand CAD | -10.73% |
| 2012 Q1 | -274.82 Thousand CAD | -54.49% |
| 2012 Q3 | -247.3 Thousand CAD | 18.74% |
| 2012 FY | -1.24 Million CAD | 33.22% |
| 2011 Q3 | -386.77 Thousand CAD | 60.8% |
| 2011 Q1 | -308.25 Thousand CAD | 33.52% |
| 2011 Q4 | -177.89 Thousand CAD | 54.0% |
| 2011 Q2 | -986.58 Thousand CAD | -220.05% |
| 2011 FY | -1.85 Million CAD | 5.02% |
| 2010 Q2 | -493.15 Thousand CAD | -15.34% |
| 2010 Q3 | -573.44 Thousand CAD | -16.28% |
| 2010 FY | -1.95 Million CAD | -83.99% |
| 2010 Q4 | -463.7 Thousand CAD | 19.14% |
| 2010 Q1 | -427.57 Thousand CAD | 0.0% |
| 2009 FY | -1.06 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | 16.331% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 69.348% |
| Blueberries Medical Corp. | -1.22 Million CAD | 18.761% |
| The BC Bud Corporation | -1.22 Million CAD | 18.556% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 84.351% |
| CordovaCann Corp. | -2.51 Million CAD | 60.341% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -13.162% |
| Captor Capital Corp. | 655.2 Thousand CAD | 252.081% |
| 1CM Inc. | 300.79 Thousand CAD | 431.277% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -80.612% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 74.312% |
| IM Cannabis Corp. | -12.17 Million CAD | 91.816% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 70.338% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -154.056% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 68.724% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 283.755% |
| Ovation Science Inc. | -764 Thousand CAD | -30.424% |
| Pharmadrug Inc. | -1.33 Million CAD | 25.36% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | 12.743% |
| RAMM Pharma Corp. | -7.08 Million CAD | 85.938% |
| RIV Capital Inc. | 1.78 Million CAD | 155.973% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 69.676% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 88.637% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 83.355% |
| 1933 Industries Inc. | -9.34 Million CAD | 89.342% |
| Red Light Holland Corp. | -6.44 Million CAD | 84.543% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -26.968% |
| Xebra Brands Ltd. | -1.55 Million CAD | 35.901% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 44.449% |